RegeneRx Biopharmaceuticals, Inc. (RGRX)의 가격은 얼마입니까?

RegeneRx Biopharmaceuticals, Inc. (RGRX)의 가격은 $0.0007입니다.

RegeneRx Biopharmaceuticals, Inc. (RGRX)의 시가 총액은 무엇입니까?

RegeneRx Biopharmaceuticals, Inc. (RGRX)의 시가 총액은 $1.05K입니다.

RegeneRx Biopharmaceuticals, Inc. (RGRX) 영업이익률

RegeneRx Biopharmaceuticals, Inc. is a biotechnology firm dedicated to the advancement of therapeutic peptides, with a primary emphasis on thymosin beta 4, engineered for the protection, repair, and regeneration of tissues and organs. The company's development pipeline includes RGN-259, a preservative-free ophthalmic solution designed to restore corneal tissues following injury, disease, or other pathologies; RGN-352, an injectable formulation under investigation for its potential in treating cardiovascular ailments, central and peripheral nervous system disorders, and various other medical conditions; and RGN-137, a topical gel aimed at accelerating the healing of skin wounds and minimizing scar tissue. Strategic alliances have been forged with Lee's Pharmaceutical Group and GtreeBNT Co., Ltd. Incorporated in 1982, the company initially operated as Alpha 1 Biomedicals, Inc., adopting the name RegeneRx Biopharmaceuticals, Inc. in 2000. Its operations are headquartered in Rockville, Maryland.

연도	영업이익률	변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.

연도

영업이익률

변화

제공된 날짜에 대한 데이터가 충분하지 않습니다.

회사	영업이익률	영업이익률 차이	국가
Vertex Pharmaceuticals Incorporated VRTX.US	38.97%	-	US
Argenx SE ARGX.US	28.81%	-	NL
Lonza Group AG LONN.SW	0.00%	-	CH
UCB S.A. UCB.BR	31.23%	-	BE
Samsung Biologics Co.,Ltd. 207940.KS	0.00%	-	KR

회사

영업이익률

영업이익률 차이

국가